Xiaofei Zhu

1.1k total citations · 1 hit paper
54 papers, 649 citations indexed

About

Xiaofei Zhu is a scholar working on Oncology, Radiation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaofei Zhu has authored 54 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 24 papers in Radiation and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaofei Zhu's work include Advanced Radiotherapy Techniques (24 papers), Pancreatic and Hepatic Oncology Research (23 papers) and Medical Imaging Techniques and Applications (10 papers). Xiaofei Zhu is often cited by papers focused on Advanced Radiotherapy Techniques (24 papers), Pancreatic and Hepatic Oncology Research (23 papers) and Medical Imaging Techniques and Applications (10 papers). Xiaofei Zhu collaborates with scholars based in China, United States and Taiwan. Xiaofei Zhu's co-authors include Huojun Zhang, Xiaoping Ju, Yangsen Cao, Fei Cao, Yuxin Shen, Fang Fang, Zhenyu Jia, Xiang Wang, Shanshan Wang and Anqi Ge and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Xiaofei Zhu

54 papers receiving 634 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review

2023 97 citations Jinsong Zeng, Tingting Bao et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaofei Zhu China	14	223	143	121	111	103	54	649
Hojin Jeong South Korea	14	100 0.4×	225 1.6×	80 0.7×	142 1.3×	126 1.2×	43	497
Bo Hyun Jung Sweden	13	263 1.2×	141 1.0×	249 2.1×	89 0.8×	104 1.0×	36	711
Le‐Tian Huang China	15	185 0.8×	260 1.8×	32 0.3×	39 0.4×	60 0.6×	51	593
Yoo‐Young Lee South Korea	16	162 0.7×	86 0.6×	183 1.5×	19 0.2×	63 0.6×	51	781
Cheng Zhou China	14	109 0.5×	201 1.4×	81 0.7×	26 0.2×	76 0.7×	53	605
Laurence Goethals Belgium	16	237 1.1×	247 1.7×	127 1.0×	117 1.1×	141 1.4×	25	832
Yiqiu Zhang China	17	95 0.4×	201 1.4×	101 0.8×	95 0.9×	579 5.6×	60	958
Eric Hernady United States	16	130 0.6×	549 3.8×	112 0.9×	84 0.8×	535 5.2×	41	1.1k
Michael Yan Canada	12	97 0.4×	139 1.0×	61 0.5×	52 0.5×	76 0.7×	43	409
Shijian Feng China	14	66 0.3×	259 1.8×	98 0.8×	38 0.3×	37 0.4×	39	618

Countries citing papers authored by Xiaofei Zhu

Since Specialization

Citations

This map shows the geographic impact of Xiaofei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Zhu more than expected).

Fields of papers citing papers by Xiaofei Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Zhu. The network helps show where Xiaofei Zhu may publish in the future.

Co-authorship network of co-authors of Xiaofei Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Zhu. A scholar is included among the top collaborators of Xiaofei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Zhu. Xiaofei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Wenyu, et al.. (2024). Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer. Radiation Oncology. 19(1). 111–111. 1 indexed citations

Zeng, Jinsong, Tingting Bao, Kailin Yang, et al.. (2023). The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review. Frontiers in Immunology. 13. 1047550–1047550. 97 indexed citations breakdown →

Jia, Zhenyu, Fang Fang, Yangsen Cao, et al.. (2023). Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study. Radiation Oncology. 18(1). 140–140. 2 indexed citations

Zhu, Xiaofei, et al.. (2023). Immune profiling of pancreatic cancer for radiotherapy with immunotherapy and targeted therapy: Biomarker analysis of a randomized phase 2 trial. Radiotherapy and Oncology. 190. 109941–109941. 4 indexed citations

Zhu, Xiaofei, et al.. (2022). Biologically effective doses of 60–70Gy versus >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a single-centre, phase II clinical trial. BMJ Open. 12(8). e049382–e049382. 1 indexed citations

Zhu, Xiaofei, Wenyu Liu, Yangsen Cao, et al.. (2021). Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy. Frontiers in Oncology. 11. 688576–688576. 3 indexed citations

Zhao, Xianzhi, Haiyan Yu, Chao Cheng, et al.. (2021). Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China. Journal of Cancer Research and Clinical Oncology. 147(12). 3557–3564. 4 indexed citations

Zhao, Xianzhi, Xiaofei Zhu, Hongqing Zhuang, et al.. (2020). Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China. Scientific Reports. 10(1). 7836–7836. 14 indexed citations

Zhu, Xiaofei, Di Chen, Yangsen Cao, et al.. (2020). Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications. Cancer Biology and Medicine. 17(2). 492–500. 1 indexed citations

10.

Chen, Di, Xiaofei Zhu, Yajun Zhang, et al.. (2020). Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency. Journal of Controlled Release. 324. 545–559. 31 indexed citations

11.

Gao, Suizhi, Xiaofei Zhu, Xiaohan Shi, et al.. (2019). Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1). Radiation Oncology. 14(1). 52–52. 11 indexed citations

12.

Gu, Lei, Xiaofei Zhu, Xiaoping Ju, et al.. (2019). Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis. Frontiers in Oncology. 9. 1352–1352. 7 indexed citations

13.

Zhu, Xiaofei, Xiaoping Ju, Yangsen Cao, et al.. (2019). Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design. International Journal of Radiation Oncology*Biology*Physics. 104(1). 101–110. 48 indexed citations

14.

Zhu, Xiaofei, Wenyu Liu, Dongchen Shi, et al.. (2018). Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database. Cancer Management and Research. Volume 10. 1295–1304. 13 indexed citations

15.

Zhu, Xiaofei, Dongchen Shi, Xiaoping Ju, et al.. (2018). Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer. Cancer Management and Research. Volume 10. 4805–4815. 6 indexed citations

16.

Zhu, Xiaofei, Xiaoping Ju, Yuxin Shen, et al.. (2018). Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score). Radiotherapy and Oncology. 129(2). 313–318. 12 indexed citations

17.

Cao, Yangsen, Xiaofei Zhu, Xiaoping Ju, et al.. (2018). Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shells. Radiation Oncology. 13(1). 11–11. 9 indexed citations

18.

Cao, Yangsen, Xiaofei Zhu, Yongming Liu, et al.. (2017). A modified formula for dose calculations of stereotactic ablative body radiotherapy for non–small cell lung cancer. Medical dosimetry. 43(3). 207–213. 1 indexed citations

19.

Zhu, Xiaofei, Xiaoping Ju, Fei Cao, et al.. (2016). Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial. BMJ Open. 6(12). e013220–e013220. 10 indexed citations

20.

Chen, Xiao, Peng Liu, Xiaofei Zhu, et al.. (2013). Design and application of Nickel-Titanium olecranon memory connector in treatment of olecranon fractures: a prospective randomized controlled trial. International Orthopaedics. 37(6). 1099–1105. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact